Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

A rare skin condition affected only the facial hair of a 46-year-old man.

A 61-year-old Filipino man had a skin condition that looked like another disease, making diagnosis difficult.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

The journal covered various dermatology topics, including treatments, disease management, and research findings.

Dr. Robert S. Haber concluded that hair transplant surgeons must master scalp biopsy techniques to quickly diagnose and treat hair loss conditions.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Some women with common hair loss may develop permanent hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Some drugs used to treat immune conditions may cause different types of hair loss.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Not all cases with typical signs of Alopecia Areata are actually diagnosed as such.

Turning off the Lhx2 gene in mouse embryos leads to slower wound healing and scars.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Acne necrotica can be effectively treated with topical cream and antibiotics.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness and are not FDA-approved.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.